Introduction
The withdrawal of the drug Champix from the Spanish market due to carcinogenic impurities has triggered a new strategy to combat tobacco dependence. For more than a year, smokers have faced high prices and adverse effects from available treatments. However, since February, the health system has begun funding Todacitan, a drug that has been on the market for a year, offering an affordable and effective alternative to smoking cessation.
What is Todacitan?
Todacitan is a medication intended to relieve anxiety associated with quitting tobacco. Its main component is Cytisine, a plant alkaloid that acts similarly to nicotine. Cytisine blocks nicotine receptors, thus reducing withdrawal symptoms and tobacco dependence. This active ingredient, present in an Eastern European tree, has been used since World War II as a tobacco substitute.
Proven Efficacy and Scientific Studies
Studies published in renowned scientific journals have demonstrated the effectiveness of Cytisine in the fight against tobacco addiction. Comparison with other treatments, such as Nicotine Replacement Therapies (NRT) and varenicline, has revealed higher abstinence rates and fewer adverse effects with the use of Cytisine.
Adverse Effects and Recommendations
Although Todacitan has been shown to be effective, it has an extensive list of possible adverse effects, which vary in intensity from person to person. Its use is discouraged in certain groups, such as pregnant women, those under 18 years of age, people over 65 years of age, and those with specific health problems. It is crucial to strictly follow dosage directions to minimize side effects.
Treatment Schedule and Cost
Treatment with Todacitan lasts 25 days and requires a specific dosing schedule, which gradually decreases throughout the period. Currently, the price of the subsidized treatment is 116.93 euros, with possible variations based on the patient’s level of contribution. It is important to highlight the limitation of one treatment financed per person per year and the requirements to access financing.
Conclusion
Todacitan represents an accessible and effective alternative for those who want to quit smoking. However, it is essential to consult with a health professional to evaluate the convenience and safety of the treatment in each particular case.
